Antibody Profile and Lupus Nephritis Risk in Saudi Patients
Author Information
Author(s): Muacevic Alexander, Adler John R, Alsalman Ahmed, Albalawi Taraq, Albalwi Faisael, Albirdisi Majed
Primary Institution: King Fahad Medical City, Riyadh, SAU
Hypothesis
Is there an association between the presence of anti-Smith, anti-Ro, and anti-RNP antibodies and the development of lupus nephritis in systemic lupus erythematosus patients?
Conclusion
The presence of anti-Sm, anti-Ro, and anti-RNP antibodies is associated with a higher risk of early lupus nephritis development within five years after initial SLE diagnosis.
Supporting Evidence
- 95% of patients with all three antibodies developed proteinuria within the first five years of SLE diagnosis.
- Patients with positive antibody profiles had a higher likelihood of developing lupus nephritis earlier.
- The study included a representative cohort reflective of routine clinical practice.
Takeaway
If you have certain antibodies, you might get kidney problems from lupus faster than others.
Methodology
A retrospective, single-center cohort study analyzing 128 SLE patients with lupus nephritis, focusing on antibody profiles and time to proteinuria development.
Potential Biases
Potential biases include recall bias and incomplete records due to the retrospective nature of the study.
Limitations
The study's retrospective design and small sample size limit the ability to establish causative relationships.
Participant Demographics
The majority of participants were Saudi (96.88%), with a median age of 30.5 years, predominantly female (85.94%).
Statistical Information
P-Value
0.0033
Confidence Interval
95% CI: 4.793-9.798
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website